Copyright
©The Author(s) 2015.
World J Gastroenterol. May 14, 2015; 21(18): 5591-5597
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5591
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5591
Figure 2 Survival curves for stage IIIA patients.
A: Cancer-specific survival (CSS); B: Recurrence-free survival (RFS) curves according to preoperative serum neutrophil-lymphocyte ratio (NLR) for patients with pathological tumor-node-metastasis stage IIIA esophageal squamous cell carcinoma
- Citation: Duan H, Zhang X, Wang FX, Cai MY, Ma GW, Yang H, Fu JH, Tan ZH, Meng YQ, Fu XY, Ma QL, Lin P. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma. World J Gastroenterol 2015; 21(18): 5591-5597
- URL: https://www.wjgnet.com/1007-9327/full/v21/i18/5591.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i18.5591